NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) announced today that it will participate in the Planet MicroCap Las Vegas 2026 Conference, scheduled for June 17-18, 2026. The company, which focuses on advancing surgical diagnosis and treatment for neurological disorders, will be represented by President and CEO Dave Rosa. He is set to deliver a company presentation on Wednesday, June 17, 2026, at 12:00 p.m. Pacific Time in TRACK 6 - Raphael 3, where he will discuss commercialization updates and anticipated milestones for the OneRF platform.
The OneRF platform is designed for treating conditions related to the brain, pain management, and advanced drug delivery. This technology is part of NeuroOne's broader portfolio, which includes FDA-cleared products such as Evo Cortical Electrodes, Evo sEEG Electrodes, and the OneRF Ablation System for both brain and trigeminal nerve procedures. The company's solutions aim to reduce hospitalizations, lower costs, and improve patient outcomes by combining diagnostic and therapeutic capabilities.
In addition to the presentation, Rosa will participate in one-on-one meetings with institutional investors and has completed a CEO interview with Planet MicroCap host Robert Kraft, which can be viewed here. The conference webcast will be accessible via this link, and more details about the event are available on the conference website.
NeuroOne's participation underscores its commitment to advancing neurological care and engaging with the investment community. The company continues to expand its research and development efforts, including programs for drug delivery, basivertebral nerve ablation, and spinal cord stimulation. For further information, visit nmtc1.com.
